This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2004-2011.
Company Filing History:
Years Active: 2004-2011
Title: Innovations by Ram Raghubir in Pharmaceutical Science
Introduction
Ram Raghubir is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceutical science, particularly in the treatment of diabetes and dyslipidemia. With a total of 3 patents to his name, Raghubir's work is recognized for its innovative approaches to health challenges.
Latest Patents
Raghubir's latest patents include a pharmaceutical composition for the treatment of diabetes and dyslipidemia. This invention features a bioactive fraction that serves as an antidiabetic and antidyslipidemic agent. The composition can be utilized in methods for treating these conditions in subjects. Another significant patent involves a process for preparing bioactive fractions from isomeric xyloccensins. This includes pharmaceutical compositions that contain therapeutically effective amounts of these compounds, which can be used in treating dyslipidemia. Additionally, he has developed novel oxy-substituted flavones that act as antihyperglycemic and antidyslipidemic agents. This invention provides a method for controlling type II diabetes and associated hyperlipidemic conditions in mammals.
Career Highlights
Ram Raghubir is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research and innovations. His work has been instrumental in developing new therapeutic options for managing diabetes and related health issues.
Collaborations
Raghubir has collaborated with notable colleagues such as Sudhir Srivastava and Arvind Kumar Srivastava. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Ram Raghubir's contributions to pharmaceutical science highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to addressing critical health challenges through scientific research and development.